Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium.
Am J Cardiol. 2010 Feb 1;105(3):333-8. doi: 10.1016/j.amjcard.2009.09.033. Epub 2009 Dec 22.
Platelet reactivity is greater in patients with stable angina and with more extensive peripheral vascular atherosclerosis. We sought to evaluate whether impaired peripheral microcirculatory endothelial function might correlate with platelet reactivity after clopidogrel and therefore predispose to an unfavorable outcome after percutaneous coronary intervention (PCI). In 52 consecutive patients with stable angina undergoing elective PCI, endothelial function was assessed by (1) endothelial peripheral arterial tonometry (measuring the "Endoscore"); (2) the von Willebrandt factor antigen level and ristocetin co-factor activity. Basal platelet reactivity was assessed by soluble P-selectin. Patients then received a 600-mg clopidogrel loading dose > or = 12 hours before PCI. A blood sample was withdrawn 12 hours later, but before PCI, to assess platelet reactivity using the P2Y12 reaction unit and percentage of P2Y12 inhibition with the point-of-care VerifyNow P2Y12 assay. Troponin T was assessed 24 hours after PCI. The Endoscore inversely correlated with von Willebrandt factor antigen activity (r = -0.52, p = 0.0001) and soluble P-selectin concentration (r = -0.36, p = 0.021), suggesting greater platelet reactivity with increased impaired endothelial function. After clopidogrel, the Endoscore correlated directly with the percentage of P2Y12 inhibition (r = 0.36, p = 0.009) and inversely with the P2Y12 reaction unit (r = -0.41, p = 0.002), suggesting greater residual platelet reactivity with more impaired endothelial function. The average Endoscore was significantly lower in patients with troponin T elevation (troponin positive group 0.267 + or - 0.091) than in patients without troponin T elevation (troponin negative group 0.508 + or - 0.041, p = 0.015 vs troponin positive). In conclusion, an impaired endothelial response before clopidogrel was associated with greater platelet reactivity after clopidogrel. This link might explain the unfavorable PCI outcomes in patients with more severe endothelial impairment.
血小板反应性在稳定型心绞痛患者和外周血管动脉粥样硬化程度更严重的患者中更高。我们试图评估外周微血管内皮功能受损是否与氯吡格雷治疗后的血小板反应性相关,并且因此导致经皮冠状动脉介入治疗(PCI)后预后不良。在 52 例接受择期 PCI 的稳定型心绞痛连续患者中,通过以下方式评估内皮功能:(1)内皮周围动脉张力测定(测量“Endoscore”);(2)血管性血友病因子抗原水平和瑞斯托霉素辅因子活性。通过可溶性 P-选择素评估基础血小板反应性。患者在 PCI 前至少 12 小时接受 600mg 氯吡格雷负荷剂量。PCI 前 12 小时抽取血样,以使用即时检验 VerifyNow P2Y12 检测评估血小板反应性,包括 P2Y12 反应单位和 P2Y12 抑制率的百分比。PCI 后 24 小时检测肌钙蛋白 T。Endoscore 与血管性血友病因子抗原活性呈负相关(r=-0.52,p=0.0001),与可溶性 P-选择素浓度呈负相关(r=-0.36,p=0.021),表明内皮功能受损越严重,血小板反应性越高。氯吡格雷治疗后,Endoscore 与 P2Y12 抑制率的百分比呈正相关(r=0.36,p=0.009),与 P2Y12 反应单位呈负相关(r=-0.41,p=0.002),表明内皮功能受损越严重,残余血小板反应性越高。肌钙蛋白 T 升高的患者的平均 Endoscore 明显低于肌钙蛋白 T 正常的患者(肌钙蛋白阳性组 0.267+/-0.091 比肌钙蛋白阴性组 0.508+/-0.041,p=0.015 比肌钙蛋白阳性组)。总之,氯吡格雷治疗前内皮反应受损与氯吡格雷治疗后血小板反应性增加相关。这种联系可能解释了内皮功能受损更严重的患者 PCI 预后不良的原因。